Developer docs
API playgroundTry for free, no card

Search company profiles

Exo

Full company profile

uuid00005mv

Namestring
Exo
Legal namestring
Exo Imaging, Inc.
Websiteurl
exo.inc
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Exo Imaging, Inc. is a privately held medical device company founded in 2015 and headquartered in Santa Clara, California, that develops handheld point-of-care ultrasound (POCUS) systems and AI-enabled imaging software. The company's flagship product is the Exo Iris, a pocket-sized ultrasound device built on proprietary Piezoelectric Micromachined Ultrasonic Transducer (pMUT) chip technology that delivers phased, curved, and linear imaging from a single probe. The platform is augmented by SweepAI, an FDA-cleared on-device AI scanning assistant; Exo U, an AI coaching and microlearning application; and Exo Works, a vendor-neutral workflow solution for documentation, quality assurance, billing, and credentialing.

Exo monetizes through hardware sales of the Exo Iris device, subscription-based Exo Works software available in Connect and Enterprise tiers, and bundled AI applications covering cardiac, lung, fluid management, and population health diagnostics. The company employs a hybrid go-to-market motion combining direct enterprise sales to health systems, an e-commerce storefront for individual practitioners, and strategic distribution partnerships, most notably a May 2025 collaboration with Samsung Medison. Named customers include Wellstar MCG Health, Geisinger, Northwestern Medicine, Medical College of Georgia, and Highland Hospital, with use cases spanning hospitals, emergency departments, critical care, cardiology, medical schools, and primary and rural care settings. As of April 2025 Exo had secured 10 FDA 510(k) clearances for AI indications.

The company has raised more than $320 million in venture capital, including a $220 million Series C in July 2021 led by RA Capital Management with participation from BlackRock, Intel, Sony Innovation Fund, and other investors. In July 2022 Exo acquired Canadian AI ultrasound firm Medo to accelerate its AI capabilities, and in May 2025 the company entered a strategic partnership with Samsung Medison accompanied by a potential $100 million investment from Samsung Ventures.

Short descriptiontext

Exo Imaging builds the Exo Iris handheld ultrasound device on proprietary pMUT chip technology, paired with FDA-cleared on-device AI applications (cardiac, lung, fluid management) and the Exo Works workflow platform, serving hospitals, EDs, medical schools, and individual clinicians.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSanta Clara, United States
HQ citystring
Santa Clara
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
handheld ultrasound devices, point-of-care ultrasound, medical imaging AI, ultrasound workflow software, AI diagnostic imaging
Industry2 codes
PRIMARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Point-of-Care Ultrasound Systems
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Sales - Exo Iris Device
TypeHardware Sales
Description

Sale of the Exo Iris handheld ultrasound device, a high-performance POCUS device priced at a fraction of traditional cart-based ultrasound systems. The device serves as the foundation of the company's medical imaging ecosystem.

exo.inc
2Software Subscriptions - Exo Works
TypeSubscription Recurring
Description

Subscription-based POCUS workflow software providing documentation, QA, billing, and credentialing capabilities. Available in Enterprise and Connect tiers with per-user or institutional pricing.

exo.inc
3AI Application Licensing
TypeLicensing Royalties
Description

FDA-cleared AI applications (cardiac, lung, fluid management, population health) integrated into the Exo Iris device and available as part of the platform. Revenue derived from device sales and potential per-feature licensing.

exo.inc
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Pricing details3 tiers
1Exo Iris handheld ultrasound device with integrated AI capabilities
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Expected to cost approximately as much as a laptop; handheld POCUS devices in the market typically range from $8,000-$10,000

exo.inc
2Exo Works Connect - streamlined POCUS workflow for clinical and educational programs
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing; designed for minimal IT effort deployment in days rather than months

exo.inc
3Exo Works Enterprise - full-featured POCUS workflow with advanced customization
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing; includes features such as fleet management, CSV bulk import, and customized credentialing by roles

exo.inc
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Exo Iris
Description

High-performance pocket-sized handheld ultrasound device with FDA-cleared AI applications for cardiac, lung, fluid management, and population health insights.

exo.inc
+3 more records
Core offering1 text field

Exo designs, manufactures, and sells a pocket-sized handheld ultrasound device (Exo Iris) powered by proprietary pMUT chip technology, bundled with FDA-cleared AI applications for cardiac, lung, fluid management, and population health diagnostics, and complemented by a cloud-based POCUS workflow software (Exo Works) for documentation, QA, billing, and credentialing. The company offers a complete medical imaging ecosystem targeting healthcare providers, health systems, and medical education institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 203% ROI within 9 months for health systems implementing Exo Works
+9 more records
Product overview1 text field

Exo offers a unified medical imaging platform centered on its Exo Iris handheld ultrasound device, combined with a modular suite of AI-powered software solutions. The platform architecture consists of Exo Iris (the core hardware device featuring proprietary pMUT chip technology), augmented by four key software modules: SweepAI (real-time scanning guidance and auto-capture), Exo U (AI-powered education and coaching), and Exo Works (workflow management for documentation, QA, billing, and credentialing). The platform delivers FDA-cleared AI applications for cardiac, lung, fluid management, and population health diagnostics. Exo also acquired Medo in 2022 to enhance its AI capabilities. The company has raised over $320 million in total funding, with Samsung Medison announcing a strategic partnership in 2025.

Product and service4 records
1Exo Iris
CategoryPoint-of-Care Ultrasound Hardware
Description

Pocket-sized, FDA-cleared handheld ultrasound device powered by proprietary pMUT chip technology. Provides high-performance whole-body ultrasound imaging with phased, curved, and linear capabilities in a smartphone-sized form factor, replacing cart-based systems for healthcare providers across emergency medicine, critical care, cardiology, and primary care settings.

2Exo Works
CategoryMedical Imaging Workflow Software
Description

Vendor-neutral POCUS workflow software solution that enables clinicians to document ultrasound exams in seconds, manage quality assurance from anywhere, automatically save to EMR and PACS, handle billing with integrated CPT codes, and track user proficiency and credentialing. Available in Connect (streamlined) and Enterprise (full-featured) tiers. Integrates with Epic, Cerner, PACS, VNA, and DICOM-enabled devices. HIPAA, HITRUST, SOC 2 Type II, ISO 27001, and ISO 27701 compliant.

3SweepAI
CategoryAI Medical Imaging Software
Description

FDA-cleared AI scanning technology that provides real-time feedback during ultrasound scanning, automatically identifying optimal imaging views, monitoring image quality, auto-capturing key views, and providing diagnostic insights without internet or cloud reliance. Functions as an autonomous scanning assistant that continuously evaluates and monitors ultrasound image quality.

4Exo U
CategoryMedical Education Software
Description

On-device AI education platform providing real-time ultrasound coaching, anatomical labeling, and microlearning videos (described as 'TikTok for POCUS'). Designed to help clinicians improve scanning skills through AI-guided probe motion and educational content.

Scale indicator19 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-27
Description

Strategic collaboration announced May 27, 2025 for Exo's portable AI-powered ultrasound device. Samsung Medison is a Samsung subsidiary specializing in medical ultrasound and digital radiography systems. Dr. Omar Ishrak, former Intel CEO and Samsung Medison chairman, joined Exo's board as part of this collaboration. The partnership aims to enhance Exo's commercial expansion and leverage Samsung's global distribution network.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-07-26
Description

Acquired by Exo in July 2022. Canadian AI technology developer focused on simplifying ultrasound use through AI. Led by Dornoosh Zonoobi, Medo had developed two FDA-cleared products and deployed in four countries before acquisition.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Implemented Exo Works workflow solution across emergency and internal medicine departments. Achieved 47% revenue capture increase and 203% ROI within 9 months. Medical College of Georgia also pilots Exo Works for student training.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Public handheld POCUS competitor using proprietary CMUT chip technology on a smartphone-connected platform with FDA-cleared AI. Closely comparable to Exo in target customers (emergency medicine, cardiology, primary care), chip-based architecture, and AI-augmented imaging strategy.

TypeDirect peer
Description

Operates the Vscan Air handheld ultrasound line competing directly with Exo Iris in cardiology, emergency medicine, and primary care. GE HealthCare brings incumbent hospital relationships, global distribution, and a broad imaging portfolio that creates both direct competition and a potential partnership channel.

TypeDirect peer
Description

Sells the Lumify handheld POCUS system, a smartphone-connected ultrasound probe targeting similar clinical settings and customer profiles as Exo Iris. Comparable through its handheld form factor, AI-enabled imaging features, and global hospital sales channel.

TypeDirect peer
Description

Vancouver-based handheld POCUS vendor offering wireless, AI-enabled ultrasound scanners for emergency medicine, critical care, and medical education. Highly comparable in product positioning, AI strategy, and target customer segments to Exo's Iris and Exo U offerings.

TypeBroad incumbent
Description

Global medical imaging incumbent with a large ultrasound portfolio across cart-based and handheld systems, including ACUSON POCUS offerings. Comparable as a broader ultrasound player that overlaps with Exo in clinical use cases but does not focus exclusively on handheld POCUS.

TypeBroad incumbent
Description

Established POCUS specialist with both handheld and cart-based ultrasound systems and a long-standing footprint in emergency medicine and anesthesia. Comparable through overlapping POCUS use cases and customer base, though SonoSite's product mix is broader than Exo's handheld focus.

TypeBroad incumbent
Description

Major imaging equipment vendor offering ultrasound systems used in hospitals and specialty practices. Comparable as a broader medical imaging incumbent with overlap in clinical ultrasound applications, though Canon's primary focus is cart-based systems.

TypeBroad incumbent
Description

Chinese medical device manufacturer offering a broad range of ultrasound systems including handheld POCUS products, with growing U.S. and international presence. Comparable through handheld POCUS product overlap, particularly in price-sensitive segments.

TypeOthers
Description

Samsung's medical imaging subsidiary focused on ultrasound and digital radiography. Listed as a peer because of its May 2025 strategic partnership with Exo and overlapping ultrasound category, while also functioning as a potential channel and investor rather than a direct handheld POCUS competitor.

TypeEmerging player
Description

Emerging handheld POCUS company focused on AI-enabled cardiac, lung, and abdominal assessment at the bedside. Comparable as a niche AI-ultrasound player targeting overlapping clinical use cases and customer segments, though with a narrower product footprint than Exo.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors27 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Exo

Point-of-Care Ultrasound Systemsexo.inc

Exo Imaging builds the Exo Iris handheld ultrasound device on proprietary pMUT chip technology, paired with FDA-cleared on-device AI applications (cardiac, lung, fluid management) and the Exo Works workflow platform, serving hospitals, EDs, medical schools, and individual clinicians.

What Exo does

Exo Imaging, Inc. is a privately held medical device company founded in 2015 and headquartered in Santa Clara, California, that develops handheld point-of-care ultrasound (POCUS) systems and AI-enabled imaging software. The company's flagship product is the Exo Iris, a pocket-sized ultrasound device built on proprietary Piezoelectric Micromachined Ultrasonic Transducer (pMUT) chip technology that delivers phased, curved, and linear imaging from a single probe. The platform is augmented by SweepAI, an FDA-cleared on-device AI scanning assistant; Exo U, an AI coaching and microlearning application; and Exo Works, a vendor-neutral workflow solution for documentation, quality assurance, billing, and credentialing.

Exo monetizes through hardware sales of the Exo Iris device, subscription-based Exo Works software available in Connect and Enterprise tiers, and bundled AI applications covering cardiac, lung, fluid management, and population health diagnostics. The company employs a hybrid go-to-market motion combining direct enterprise sales to health systems, an e-commerce storefront for individual practitioners, and strategic distribution partnerships, most notably a May 2025 collaboration with Samsung Medison. Named customers include Wellstar MCG Health, Geisinger, Northwestern Medicine, Medical College of Georgia, and Highland Hospital, with use cases spanning hospitals, emergency departments, critical care, cardiology, medical schools, and primary and rural care settings. As of April 2025 Exo had secured 10 FDA 510(k) clearances for AI indications.

The company has raised more than $320 million in venture capital, including a $220 million Series C in July 2021 led by RA Capital Management with participation from BlackRock, Intel, Sony Innovation Fund, and other investors. In July 2022 Exo acquired Canadian AI ultrasound firm Medo to accelerate its AI capabilities, and in May 2025 the company entered a strategic partnership with Samsung Medison accompanied by a potential $100 million investment from Samsung Ventures.

Exo firmographics

Firmographics
Name
Exo
Legal name
Exo Imaging, Inc.
Website
https://exo.inc
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
101–250 employees
Short description
Exo Imaging builds the Exo Iris handheld ultrasound device on proprietary pMUT chip technology, paired with FDA-cleared on-device AI applications (cardiac, lung, fluid management) and the Exo Works workflow platform, serving hospitals, EDs, medical schools, and individual clinicians.
Ownership category
akta.pro rank

Exo industry classification

Industry
Product category
Point-of-Care Ultrasound Systems
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Handheld ultrasound devices
  • Point-of-care ultrasound
  • Medical imaging AI
  • Ultrasound workflow software
  • AI diagnostic imaging

Where Exo is headquartered

Location

Headquarters

HQ city
Santa Clara
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Exo business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Hardware Sales - Exo Iris Device: Sale of the Exo Iris handheld ultrasound device, a high-performance POCUS device priced at a fraction of traditional cart-based ultrasound systems. The device serves as the foundation of the company's medical imaging ecosystem.
  2. Software Subscriptions - Exo Works: Subscription-based POCUS workflow software providing documentation, QA, billing, and credentialing capabilities. Available in Enterprise and Connect tiers with per-user or institutional pricing.
  3. AI Application Licensing: FDA-cleared AI applications (cardiac, lung, fluid management, population health) integrated into the Exo Iris device and available as part of the platform. Revenue derived from device sales and potential per-feature licensing.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goExo Iris handheld ultrasound device with integrated AI capabilities
SubscriptionAnnualExo Works Connect - streamlined POCUS workflow for clinical and educational programs
SubscriptionAnnualExo Works Enterprise - full-featured POCUS workflow with advanced customization

Go-to-market motion3 records

Distribution channels5 records

Marketing channels8 records

Exo product offering

Product offering

Core offering

Exo designs, manufactures, and sells a pocket-sized handheld ultrasound device (Exo Iris) powered by proprietary pMUT chip technology, bundled with FDA-cleared AI applications for cardiac, lung, fluid management, and population health diagnostics, and complemented by a cloud-based POCUS workflow software (Exo Works) for documentation, QA, billing, and credentialing. The company offers a complete medical imaging ecosystem targeting healthcare providers, health systems, and medical education institutions.

Product overview

Exo offers a unified medical imaging platform centered on its Exo Iris handheld ultrasound device, combined with a modular suite of AI-powered software solutions. The platform architecture consists of Exo Iris (the core hardware device featuring proprietary pMUT chip technology), augmented by four key software modules: SweepAI (real-time scanning guidance and auto-capture), Exo U (AI-powered education and coaching), and Exo Works (workflow management for documentation, QA, billing, and credentialing). The platform delivers FDA-cleared AI applications for cardiac, lung, fluid management, and population health diagnostics. Exo also acquired Medo in 2022 to enhance its AI capabilities. The company has raised over $320 million in total funding, with Samsung Medison announcing a strategic partnership in 2025.

Differentiator

Problem solved

Functional benefit

Brands

  • Exo Iris: High-performance pocket-sized handheld ultrasound device with FDA-cleared AI applications for cardiac, lung, fluid management, and population health insights.
  • Exo Works
  • SweepAI
  • Exo U

Products and services

  • Exo Iris Pocket-sized, FDA-cleared handheld ultrasound device powered by proprietary pMUT chip technology. Provides high-performance whole-body ultrasound imaging with phased, curved, and linear capabilities in a smartphone-sized form factor, replacing cart-based systems for healthcare providers across emergency medicine, critical care, cardiology, and primary care settings.
  • Exo Works Vendor-neutral POCUS workflow software solution that enables clinicians to document ultrasound exams in seconds, manage quality assurance from anywhere, automatically save to EMR and PACS, handle billing with integrated CPT codes, and track user proficiency and credentialing. Available in Connect (streamlined) and Enterprise (full-featured) tiers. Integrates with Epic, Cerner, PACS, VNA, and DICOM-enabled devices. HIPAA, HITRUST, SOC 2 Type II, ISO 27001, and ISO 27701 compliant.
  • SweepAI FDA-cleared AI scanning technology that provides real-time feedback during ultrasound scanning, automatically identifying optimal imaging views, monitoring image quality, auto-capturing key views, and providing diagnostic insights without internet or cloud reliance. Functions as an autonomous scanning assistant that continuously evaluates and monitors ultrasound image quality.
  • Exo U On-device AI education platform providing real-time ultrasound coaching, anatomical labeling, and microlearning videos (described as 'TikTok for POCUS'). Designed to help clinicians improve scanning skills through AI-guided probe motion and educational content.

Quantifiable outcome

  • 203% ROI within 9 months for health systems implementing Exo Works
  • +9 more outcomes

Companies that use Exo

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Exo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability4 records

Feature9 records

Exo partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Samsung MedisoncoreStrategic or Co-development Partner · 27 May 2025Strategic collaboration announced May 27, 2025 for Exo's portable AI-powered ultrasound device. Samsung Medison is a Samsung subsidiary specializing in medical ultrasound and digital radiography systems. Dr. Omar Ishrak, former Intel CEO and Samsung Medison chairman, joined Exo's board as part of this collaboration. The partnership aims to enhance Exo's commercial expansion and leverage Samsung's global distribution network.
  • MedocoreStrategic or Co-development Partner · 26 July 2022Acquired by Exo in July 2022. Canadian AI technology developer focused on simplifying ultrasound use through AI. Led by Dornoosh Zonoobi, Medo had developed two FDA-cleared products and deployed in four countries before acquisition.
  • Wellstar MCG HealthcoreImplementation/ SI/ Consulting PartnerImplemented Exo Works workflow solution across emergency and internal medicine departments. Achieved 47% revenue capture increase and 203% ROI within 9 months. Medical College of Georgia also pilots Exo Works for student training.

Scale indicators19 records

Recent moves1 record

Expansion highlights6 records

Exo competitors and assessment

Company assessment

Direct peers

  • Butterfly Network: Public handheld POCUS competitor using proprietary CMUT chip technology on a smartphone-connected platform with FDA-cleared AI. Closely comparable to Exo in target customers (emergency medicine, cardiology, primary care), chip-based architecture, and AI-augmented imaging strategy.
  • GE HealthCare: Operates the Vscan Air handheld ultrasound line competing directly with Exo Iris in cardiology, emergency medicine, and primary care. GE HealthCare brings incumbent hospital relationships, global distribution, and a broad imaging portfolio that creates both direct competition and a potential partnership channel.
  • Philips: Sells the Lumify handheld POCUS system, a smartphone-connected ultrasound probe targeting similar clinical settings and customer profiles as Exo Iris. Comparable through its handheld form factor, AI-enabled imaging features, and global hospital sales channel.
  • Clarius Mobile Health: Vancouver-based handheld POCUS vendor offering wireless, AI-enabled ultrasound scanners for emergency medicine, critical care, and medical education. Highly comparable in product positioning, AI strategy, and target customer segments to Exo's Iris and Exo U offerings.

Broad incumbents

  • Siemens Healthineers: Global medical imaging incumbent with a large ultrasound portfolio across cart-based and handheld systems, including ACUSON POCUS offerings. Comparable as a broader ultrasound player that overlaps with Exo in clinical use cases but does not focus exclusively on handheld POCUS.
  • Fujifilm SonoSite: Established POCUS specialist with both handheld and cart-based ultrasound systems and a long-standing footprint in emergency medicine and anesthesia. Comparable through overlapping POCUS use cases and customer base, though SonoSite's product mix is broader than Exo's handheld focus.
  • Canon Medical Systems: Major imaging equipment vendor offering ultrasound systems used in hospitals and specialty practices. Comparable as a broader medical imaging incumbent with overlap in clinical ultrasound applications, though Canon's primary focus is cart-based systems.
  • Mindray: Chinese medical device manufacturer offering a broad range of ultrasound systems including handheld POCUS products, with growing U.S. and international presence. Comparable through handheld POCUS product overlap, particularly in price-sensitive segments.

Others

  • Samsung Medison: Samsung's medical imaging subsidiary focused on ultrasound and digital radiography. Listed as a peer because of its May 2025 strategic partnership with Exo and overlapping ultrasound category, while also functioning as a potential channel and investor rather than a direct handheld POCUS competitor.

Emerging players

  • EchoNous: Emerging handheld POCUS company focused on AI-enabled cardiac, lung, and abdominal assessment at the bedside. Comparable as a niche AI-ultrasound player targeting overlapping clinical use cases and customer segments, though with a narrower product footprint than Exo.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Exo social profiles

Digital presence

Exo compliance and trust

Trust signal

Compliance7 records

Exo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Exo leadership team

Management profile

Number of profiles

Profiles12 records

Exo subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Exo funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors27 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Exo M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Exo

What does Exo do?

Exo designs, manufactures, and sells a pocket-sized handheld ultrasound device (Exo Iris) powered by proprietary pMUT chip technology, bundled with FDA-cleared AI applications for cardiac, lung, fluid management, and population health diagnostics, and complemented by a cloud-based POCUS workflow software (Exo Works) for documentation, QA, billing, and credentialing. The company offers a complete medical imaging ecosystem targeting healthcare providers, health systems, and medical education institutions.

Is Exo a public or private company?

Exo is a private company. It is classified as venture growth investor backed and is currently operating.

When was Exo founded?

Exo was founded in 2015. It employs 101 to 250 people.

Where is Exo based?

Exo is headquartered in Santa Clara, United States, in the North America region.

How does Exo make money?

Three revenue lines are on record. Hardware Sales - Exo Iris Device is the primary driver. The others are software Subscriptions - Exo Works and AI Application Licensing.

Who are Exo's main competitors?

Direct peers on record are Butterfly Network, GE HealthCare, Philips and Clarius Mobile Health. Broad incumbents are Siemens Healthineers, Fujifilm SonoSite, Canon Medical Systems and Mindray. Samsung Medison is listed as an others. EchoNous is listed as an emerging player.

Does Exo have an API?

No public API is recorded for Exo.

What industry is Exo in?

Exo's product category is Point-of-Care Ultrasound Systems. Its primary akta.pro industry code is HLAHABAD, Ultrasound & Echography Systems, with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogExo Removes the Subscription Barrier for Handheld UltrasoundExo announced expanded deployment options for its Exo Iris handheld ultrasound platform, introducing a subscription-free model alongside its existing connected cloud service. This strategic shift allows healthcare providers to choose between ongoing subscriptions for enterprise features or one-time activation for standalone use, aiming to remove adoption barriers in disconnected environments. The move broadens the device's accessibility across diverse clinical settings, from large hospital systems to independent rural practitioners.Stock TitanNurExone unit signs U.S. exosome manufacturing LOINurExone Biologic's wholly owned U.S. subsidiary Exo-Top has signed a non-binding Letter of Intent with Florida-based BioXtek to explore a strategic partnership for manufacturing and commercializing bone marrow-derived mesenchymal stem cell exosomes. The collaboration aims to combine Exo-Top's proprietary Master Cell Bank and exosome production expertise with BioXtek's U.S. GMP manufacturing infrastructure to support clinical supply and expand production capacity. The partnership targets the rapidly growing exosome-based regenerative aesthetics market projected to surpass $1.6 billion by 2034, and may also support clinical trials for NurExone's lead drug candidate ExoPTEN targeting acute spinal cord injury and optic nerve damage.openPR.comOverview of Segmentation, Market Dynamics, and Competitive Landscape in the Medical Imaging Equipment MarketThe medical imaging equipment market is projected to reach $63.5 billion by 2030, growing at a compound annual growth rate of 5.5%, driven by AI-powered diagnostic tools, point-of-care imaging solutions, and increased investments in advanced imaging technologies. In July 2023, US-based Radon Medical Imaging LLC acquired Tristate Biomedical Solutions LLC to enhance its maintenance and repair service offerings and broaden its geographical reach. In September 2023, US-based startup Exo Inc. introduced the Exo Iris, a compact point-of-care ultrasound device with an ultra-wide 150-degree field of view.KoreatimesHow K-pop turned lore into production systemThe article discusses the evolution of lore and fictional universes in K-pop, highlighting key acts like EXO and BTS that used storytelling to build their brands. Over time, K-pop's approach shifted from fantasy-based narratives to more flexible and technologically integrated forms of world-building, with recent trends emphasizing simpler, catchier content.TracxnTop startups in Point of Care Diagnostics in United States (Nov, 2025)Several startups in the Point of Care Diagnostics sector have been highlighted, including Exo, LumiraDx, EchoNous, and Abaxis, all based in the United States. Notably, these companies are involved in developing advanced medical diagnostic technologies, with significant funding raised in recent years; for instance, Exo has secured $428 million in total funding since its founding in 2015.MedicalstartupsTop 11 Ultrasound startups 2025This article presents a curated list of the top 11 ultrasound startups for 2025, highlighting companies developing mobile devices, advanced transducers, and AI-based image analysis platforms. It provides specific funding amounts and country origins for each entity, such as Exo ($337M in the USA) and Neural Analytics ($73.7M in the USA). The report covers a global range of innovators including Encord (UK), iThera Medical (Germany), and Nabz Ava (Iran).MedicalstartupsTop 86 Medical Imaging startups 2025The article presents a curated list of the top 86 medical imaging startups for 2025, highlighting companies developing AI-powered diagnostic tools and advanced medical equipment. It details the funding levels and specific technological focuses of leading entities such as Lunit, Aidoc, and Exo across various global markets. The compilation serves as an industry overview of key players driving innovation in MRI, CT, ultrasound, and X-ray technologies.The Times of IndiaUS firm to launch 'revolutionary' portable AI ultrasound device in Bangladesh - The Economic TimesExo Imaging, a US-based medical technology company, has announced plans to launch its FDA-approved AI-powered portable ultrasound device in Bangladesh, marking its first deployment in Asia. The company's co-founders met with Bangladesh's Chief Adviser Professor Muhammad Yunus to discuss the initiative, which aims to bring diagnostics closer to patients, starting with leading hospitals before expanding to rural healthcare centres. Bangladesh is the first Asian country to adopt the technology, with plans to later expand to Mexico and Latin American countries.The Economic TimesUS firm to launch 'revolutionary' portable AI ultrasound device in BangladeshExo Imaging, a US-based company, plans to introduce its AI-powered portable ultrasound device in Bangladesh, its first Asian deployment. The FDA-approved device aims to improve rural healthcare access by enabling early detection and reducing wait times.StartupNews.fyiSamsung may invest in $100M round for medical imaging startup ExoSamsung's venture investment unit is considering a $100 million investment in medical imaging startup Exo, led by Sands Capital, Bold Capital, and Qubit Health Capital. Qubit's chairman Omar Ishrak would join Exo's board. Exo, founded in 2015, makes handheld ultrasound devices using AI and silicon technology.